The American Kratom Association: Protecting Kratom Consumers
Register for 3/25 National Advocacy Webinar
〰️
Register for 3/25 National Advocacy Webinar 〰️
YOU CAN PROTECT KRATOM CONSUMERS BY CONTACTING YOUR CONGRESSIONAL REPRESENTATIVES
SIMPLY USE THE FORMS TO CALL AND EMAIL YOUR STATE AND DISTRICT REPRESENTATIVES
All you need to do is share your story to make a difference!
Why does protecting kratom matter?
Watch and see why Americans like Michael and millions of others care so much about protecting kratom access
Seen us on tv? Watch it again here
We need to #ProtectKratom because #KratomSavesLives! Watch the stories of how kratom helps everyday Americans and then get involved today!
Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) thinks we should be studying kratom – not classifying it as a Schedule I drug. Dr. Volkow points to exciting new basic science that “point toward the potential of this drug [kratom] in pain research as well as the need for further research on the pharmacology of kratom’s constituents, their toxicity and potential value in the treatment of Opioid Use Disorder (OUD)”
-Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA)
https://www.drugabuse.gov/about-nida/noras-blog/2020/01/reviewing-nidas-2019-achievements-looking-to-future